Polyradiculoneuropathy induced by gold therapy.
Navaux
F
F
Cantagrel
A
A
Larrue
V
V
Mazières
B
B
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D050607:Organogold Compounds; D011129:Polyradiculoneuropathy / Q000139:chemically induced*
D018501:Antirheumatic Agents; D050607:Organogold Compounds